Publications by authors named "Jennifer T Fine"

Claim this Profile
A
Association of Echocardiographic Parameters and Health Status in Patients With Obstructive Hypertrophic Cardiomyopathy: Insights From EXPLORER-HCM.
Suzanne V Arnold, Kensey L Gosch, Chantal Dolan, Jennifer T Fine, Ahmad Masri

Circulation· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contemporary Challenges in Polycythemia Vera Management From the Perspective of Patients and Physicians.
Andrew T Kuykendall, Jennifer T Fine, Marina Kremyanskaya

Clin Lymphoma Myeloma Leuk· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frequency and clinicoeconomic impact of delays to definitive diagnosis of obstructive hypertrophic cardiomyopathy in the United States.
Srihari S Naidu, Megan B Sutton, Wei Gao, Jennifer T Fine, Jipan Xie

J Med Econ· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Outcomes, Resource Utilization, and Treatment Over the Disease Course of Symptomatic Obstructive Hypertrophic Cardiomyopathy in the United States.
Nihar R Desai, Megan B Sutton, Jipan Xie, Jennifer T Fine, Wei Gao

Am J Cardiol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of the Kansas City Cardiomyopathy Questionnaire in Symptomatic Obstructive Hypertrophic Cardiomyopathy.
Michael Nassif, Jennifer T Fine, Chantal Dolan, Matthew Reaney, Prithvi Addepalli

JACC Heart Fail· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal Psychometric Analysis of the Hypertrophic Cardiomyopathy Symptom Questionnaire (HCMSQ) Using Outcomes from the Phase III EXPLORER-HCM Trial.
Matthew Reaney, Prithvi Addepalli, Veleka Allen, John A Spertus, Chantal Dolan, Jennifer T Fine

Pharmacoecon Open· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment Changes, Healthcare Resource Utilization, and Costs Among Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy: A Claims Database Study.
Anjali T Owens, Megan B Sutton, Wei Gao, Jennifer T Fine, Jipan Xie

Cardiol Ther· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Projecting the Long-term Clinical Value of Mavacamten for the Treatment of Obstructive Hypertrophic Cardiomyopathy in the United States: An Assessment of Net Health Benefit.
Nihar Desai, Jipan Xie, Yan Wang, Megan B Sutton, John Whang, Jennifer T Fine

Clin Ther· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing health-related quality-of-life in patients with symptomatic obstructive hypertrophic cardiomyopathy: EQ-5D-based utilities in the EXPLORER-HCM trial.
Jipan Xie, Yan Wang, Yaping Xu, Jennifer T Fine, Jenny Lam

J Med Econ· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and economic burden of obstructive hypertrophic cardiomyopathy in the United States.
Sneha S Jain, Sophia S Li, Jipan Xie, Megan B Sutton, Jennifer T Fine

J Med Econ· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): health status analysis of a randomised, double-blind, placebo-controlled, phase 3 trial.
John A Spertus, Jennifer T Fine, Perry Elliott, Carolyn Y Ho, Iacopo Olivotto

Lancet· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author response: Validation of the National Eye Institute Visual Function Questionnaire-25 (NEIVFQ-25) in age-related macular degeneration.
Peggy Orr, Anne M Rentz, Mary Kay Margolis, Dennis A Revicki, Chantal M Dolan, Jennifer T Fine

Invest Ophthalmol Vis Sci· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of the National Eye Institute Visual Function Questionnaire-25 (NEI VFQ-25) in age-related macular degeneration.
Peggy Orr, Anne M Rentz, Mary Kay Margolis, Dennis A Revicki, Chantal M Dolan, Jennifer T Fine

Invest Ophthalmol Vis Sci· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vision-related function after ranibizumab treatment by better- or worse-seeing eye: clinical trial results from MARINA and ANCHOR.
Neil M Bressler, Tom S Chang, Ivan J Suñer, Jennifer T Fine, Chantal M Dolan

Ophthalmology· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved vision-related function after ranibizumab vs photodynamic therapy: a randomized clinical trial.
Neil M Bressler, Tom S Chang, Jennifer T Fine, Chantal M Dolan, James Ward

Arch Ophthalmol· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved vision-related function after ranibizumab treatment of neovascular age-related macular degeneration: results of a randomized clinical trial.
Tom S Chang, Neil M Bressler, Jennifer T Fine, Chantal M Dolan, James Ward

Arch Ophthalmol· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis